{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:34:55Z","timestamp":1794638095154,"version":"4.9.1"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There is a growing public concern about diabetic kidney disease (DKD), which poses a severe threat to human health and life. It is important to discover noninvasive and sensitive immune-associated biomarkers that can be used to predict DKD development. ScRNA-seq and transcriptome sequencing were performed here to identify cell types and key genes associated with DKD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here, this study conducted the analysis through five microarray datasets of DKD (GSE131882, GSE1009, GSE30528, GSE96804, and GSE104948) from gene expression omnibus (GEO). We performed single-cell RNA sequencing analysis (GSE131882) by using CellMarker and CellPhoneDB on public datasets to identify the specific cell types and cell-cell interaction networks related to DKD. DEGs were identified from four datasets (GSE1009, GSE30528, GSE96804, and GSE104948). The regulatory relationship between DKD-related characters and genes was evaluated by using WGCNA analysis. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) datasets were applied to define the enrichment of each term. Subsequently, immune cell infiltration between DKD and the control group was identified by using the \u201cpheatmap\u201d package, and the connection Matrix between the core genes and immune cell or function was illuminated through the \u201ccorrplot\u201d package. Furthermore, RcisTarget and GSEA were conducted on public datasets for the analysis of the regulation relationship of key genes and it revealed the correlation between 3 key genes and top the 20 genetic factors involved in DKD. Finally, the expression of key genes between patients with 35 DKD and 35 healthy controls were examined by ELISA, and the relationship between the development of DKD rate and hub gene plasma levels was assessed in a cohort of 35 DKD patients. In addition, we carried out immunohistochemistry and western blot to verify the expression of three key genes in the kidney tissue samples we obtained.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 8 cell types between DKD and the control group, and the number of connections between macrophages and other cells was higher than that of the other seven cell groups. We identified 356 different expression genes (DEGs) from the RNA-seq, which are enriched in urogenital system development, kidney development, platelet alpha granule, and glycosaminoglycan binding pathways. And WGCNA was conducted to construct 13 gene modules. The highest correlations module is related to the regulation of cell adhesion, positive regulation of locomotion, PI3K-Akt, gamma response, epithelial-mesenchymal transition, and E2F target signaling pathway. Then we overlapped the DEGs, WGCNA, and scRNA-seq, SLIT3, PDE1A and CFH were screened as the closely related genes to DKD. In addition, the findings of immunological infiltration revealed a remarkable positive link between T cells gamma delta, Macrophages M2, resting mast cells, and the three critical genes SLIT3, PDE1A, and CFH. Neutrophils were considerably negatively connected with the three key genes. Comparatively to healthy controls, DKD patients showed high levels of SLIT3, PDE1A, and CFH. Despite this, higher SLIT3, PDE1A, and CFH were associated with an end point rate based on a median follow-up of 2.6 years. And with the gradual deterioration of DKD, the expression of SLIT3, PDE1A, and CFH gradually increased.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The 3 immune-associated genes could be used as diagnostic markers and therapeutic targets of DKD. Additionally, we found new pathogenic mechanisms associated with immune cells in DKD, which might lead to therapeutic targets against these cells.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1030198","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T12:54:13Z","timestamp":1680094453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":132,"title":["Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Xueqin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miiriban","family":"Wusiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic kidney disease","author":"Thomas","year":"2015","journal-title":"Nat Rev Dis primers."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199401063300103","article-title":"Declining incidence of nephropathy in insulin-dependent diabetes mellitus","volume":"330","author":"Mats","year":"1994","journal-title":"New Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.4.1258","article-title":"Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes","volume":"26","author":"Hovind","year":"2003","journal-title":"Diabetes Care"},{"key":"B4","article-title":"Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes \u2013 united states and Puerto Rico 1996-2007","volume":"59","author":"Burrows","year":"2010","journal-title":"Mmwr Morb Mortal Wkly Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF diabetes atlas: Global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: Challenges, progress, and possibilities","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198905043201801","article-title":"Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic","volume":"320","author":"Seaquist","year":"1989","journal-title":"New Engl J Med"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1038\/ki.1992.112","article-title":"Borch-johnsen, k. et\u00a0al. is diabetic nephropathy an inherited complication","volume":"41","author":"Borch-Johnsen","year":"1992","journal-title":"Kidney Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0450-2","article-title":"Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy","volume":"42","author":"Du","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"B10","article-title":"Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1\u03b1-mediated renal mitochondrial protection","volume":"534","author":"Lee","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"B12","article-title":"Diabetic nephropathy on renal biopsy in the absence of clinical diabetes mellitus","volume":"75","author":"Hasan","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B13","article-title":"Podocyte EGFR inhibits autophagy through upregulation of Rubicon in type II diabetic nephropathy","volume":"70","author":"Li","year":"2020","journal-title":"Diabetes"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136994","article-title":"Molecular markers of tubulointerstitial fibrosis and tubular cell damage in patients with chronic kidney disease","volume":"10","author":"Nakagawa","year":"2015","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17901","DOI":"10.1038\/srep17901","article-title":"Identification of genes associated with Smad3-dependent renal injury by RNA-seq-based transcriptome analysis","volume":"5","author":"Zhou","year":"2015","journal-title":"entific Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.06.033","article-title":"The promise of single-cell RNA sequencing for kidney disease investigation","volume":"92","author":"Wu","year":"2017","journal-title":"Kidney Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12078","article-title":"Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy","volume":"40","author":"Ding","year":"2020","journal-title":"Cancer Commun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"Hafemeister","year":"2019","journal-title":"Genome Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018090896","article-title":"Single-cell RNA profiling of glomerular cells shows dynamic changes in experimental diabetic kidney disease","volume":"30","author":"Fu","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.798316","article-title":"Single-cell RNA sequencing profiles identify important pathophysiologic factors in the progression of diabetic nephropathy","volume":"10","author":"Lu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an r package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30195","article-title":"Diabetic kidney disease-predisposing proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (WGCNA)","volume":"123","author":"Chen","year":"2022","journal-title":"J Cell Biochem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab185","article-title":"Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study","volume":"37","author":"Yamanouchi","year":"2021","journal-title":"Nephrol Dialysis Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8572509","article-title":"Serum proteome alterations in patients with cognitive impairment after traumatic brain injury revealed by iTRAQ-based quantitative proteomics","volume":"2017","author":"Xiong","year":"2017","journal-title":"BioMed Res Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/srep20040","article-title":"Xuefu zhuyu decoction, a traditional Chinese medicine, provides neuroprotection in a rat model of traumatic brain injury via an anti-inflammatory pathway","volume":"6","author":"Xing","year":"2016","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2787-y","article-title":"A comprehensive analysis of candidate genes and pathways in pancreatic cancer","volume":"36","author":"Liu","year":"2015","journal-title":"Tumour Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1038\/s41467-020-17281-7","article-title":"Searching large-scale scRNA-seq databases via unbiased cell embedding with cell BLAST","volume":"11","author":"Cao","year":"2020","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/bfgp\/elaa003","article-title":"Identifying cell types to interpret scRNA-seq data: how, why and more possibilities","volume":"19","author":"Wang","year":"2020","journal-title":"Briefings Funct Genomics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00367.x","article-title":"Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury","volume":"65","author":"Chow","year":"2004","journal-title":"Kidney Int"},{"key":"B30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2337\/db16-0773","article-title":"Macrophage cyclooxygenase-2 protects against development of diabetic nephropathy","volume":"66","author":"Xin","year":"2017","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.intimp.2015.01.003","article-title":"Enalapril treatment increases T cell number and promotes polarization towards M1-like macrophages locally in diabetic nephropathy","volume":"25","author":"Cucak","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1159\/000321034","article-title":"Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus","volume":"118","author":"Zheng","year":"2011","journal-title":"Nephron Exp Nephrol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-015-0151-z","article-title":"Pentraxin-3 attenuates renal damage in diabetic nephropathy by promoting M2 macrophage differentiation","volume":"38","author":"Sun","year":"2015","journal-title":"Inflammation"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1020","article-title":"Vitamin d prevents podocyte injury via regulation of macrophage M1\/M2 phenotype in diabetic nephropathy rats","author":"Zhang","year":"2014","journal-title":"Endocrinology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3892\/ijo.2019.4800","article-title":"Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy","volume":"55","author":"Ji","year":"2019","journal-title":"Int J Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00482-9","article-title":"Slit3 secreted from M2-like macrophages increases sympathetic activity and thermogenesis in adipose tissue","volume":"3","author":"Wang","year":"2021","journal-title":"Nat Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/jci91086","article-title":"Osteoclast-secreted SLIT3 coordinates bone resorption and formation","volume":"128","author":"Kim","year":"2018","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12769","article-title":"SLIT3 promotes myogenic differentiation as a novel therapeutic factor against muscle loss","volume":"12","author":"Cho","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2020.02.087","article-title":"Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells","volume":"150","author":"Wang","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2019121261","article-title":"LIM-nebulette reinforces podocyte structural integrity by linking actin and vimentin filaments","volume":"31","author":"Ge","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107858","article-title":"Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities","volume":"226","author":"Samidurai","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu036","article-title":"Complement factor h gene associations with end-stage kidney disease in African americans","author":"Bonomo","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7524","article-title":"Identification of potential therapeutic target genes in mouse mesangial cells associated with diabetic nephropathy using bioinformatics analysis","volume":"17","author":"Mou","year":"2019","journal-title":"Exp Ther Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9204201","article-title":"Integrated bioinformatics and clinical correlation analysis of key genes, pathways, and potential therapeutic agents related to diabetic nephropathy","volume":"2022","author":"Chen","year":"2022","journal-title":"Dis Markers"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.864407","article-title":"Screening of the key genes and signalling pathways for diabetic nephropathy using bioinformatics analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.931282","article-title":"Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease","volume":"13","author":"Yu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1159\/000334928","article-title":"Aberrant recruitment and activation of T cells in diabetic nephropathy","volume":"35","author":"Moon","year":"2012","journal-title":"Am J Nephrol"},{"key":"B48","first-page":"215763","article-title":"The soluble form of CTLA-4 from serum of patients with autoimmune diseases regulates T-cell responses","volume":"2014","author":"Simone","year":"2015","journal-title":"BioMed Res Int"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152315","article-title":"Abatacept treatment does not preserve renal function in the streptozocin-induced model of diabetic nephropathy","volume":"11","author":"Norlin","year":"2016","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108423","article-title":"TNF-alpha pathway and T-cell immunity are activated early during the development of diabetic nephropathy in type II diabetes mellitus","volume":"215","author":"Lampropoulou","year":"2020","journal-title":"Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012020133","article-title":"Podocytes are nonhematopoietic professional antigen-presenting cells","volume":"24","author":"Goldwich","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013050518","article-title":"Role of podocyte B7-1 in diabetic nephropathy","volume":"25","author":"Fiorina","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-022516-034219","article-title":"Macrophages in renal injury and repair","volume":"79","author":"Huen","year":"2017","journal-title":"Annu Rev Physiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.08.035","article-title":"Extracellular traps in kidney disease","volume":"94","author":"Nakazawa","year":"2018","journal-title":"Kidney Int"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1960766","article-title":"Identification of fibronectin 1 (FN1) and complement component 3 (C3) as immune infiltration-related biomarkers for diabetic nephropathy using integrated bioinformatic analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.05.014","article-title":"Decreased number of CD19(+)CD24(hi)CD38(hi) regulatory b cells in diabetic nephropathy","volume":"112","author":"Li","year":"2019","journal-title":"Mol Immunol"},{"key":"B57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/sji.12128","article-title":"Functional implications of regulatory b cells in human IgA nephropathy","volume":"79","author":"Wang","year":"2014","journal-title":"Scandinavian J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2972-z","article-title":"Transcription factor Ptf1a in development, diseases and reprogramming","volume":"76","author":"Jin","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B59","article-title":"Whole-exome sequencing in a family with multiple cases of early-onset diabetes reveals a candidate causative mutation in the PTF1A gene","volume":"63","author":"Tanaka","year":"2020","journal-title":"Diabetologia"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2337\/db20-1660-P","article-title":"Exome sequencing in a family with multiple cases of early-onset diabetes reveals a candidate causative mutation in the PTF1A gene","volume":"69","author":"Tanaka","year":"2020","journal-title":"Diabetes"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.5162","article-title":"Neonatal diabetes: Two cases with isolated pancreas agenesis due to homozygous PTF1A enhancer mutations and one with developmental delay, epilepsy, and neonatal diabetes syndrome due to KCNJ11 mutation","volume":"10","author":"Evliyaoglu","year":"2018","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/ng.2826","article-title":"Enhancer cause isolated pancreatic agenesis","volume":"46","author":"Weedon","year":"2014","journal-title":"Nat Genet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1530\/EJE-14-0852","article-title":"Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes from the south-Eastern region of Turkey: predominance of non-KATP channel mutations","volume":"172","author":"Demirbilek","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1159\/000435782","article-title":"Variable phenotype of diabetes mellitus in siblings with a homozygous PTF1A enhancer mutation","volume":"84","author":"Gonc","year":"2015","journal-title":"Hormone Res Pdiatrics"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.4494","article-title":"Pancreatic agenesis due to compound heterozygosity for a novel enhancer and truncating mutation in the PTF1A gene","volume":"9","author":"Gabbay","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"458","DOI":"10.24953\/turkjped.2017.04.013","article-title":"Conventional insulin pump therapy in two neonatal diabetes patients harboring the homozygous PTF1A enhancer mutation: Need for a novel approach for the management of neonatal diabetes","volume":"59","author":"Kurnaz","year":"2017","journal-title":"Turkish J Pediatr"},{"key":"B67","article-title":"Perspectives on the contribution of genetics to the pathogenesis of type 2 diabetes mellitus","volume":"102","author":"Brunetti","year":"2011","journal-title":"Recenti Progressi Med."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4238\/2015.March.13.9","article-title":"Associations between INSR and MTOR polymorphisms in type 2 diabetes mellitus and diabetic nephropathy in a northeast Chinese han population","volume":"14","author":"Zhu","year":"2015","journal-title":"Genet Mol Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24406","article-title":"Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney","volume":"114","author":"Gatica","year":"2013","journal-title":"J Cell Biochem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/ng1297-384","article-title":"Mutation in hepatocyte nuclear factor-1 beta gene (TCF 2) associated with MODY","volume":"17","author":"Horikawa","year":"1997","journal-title":"Nat Genet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"10531","DOI":"10.1038\/ncomms10531","article-title":"Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes","volume":"7","author":"Imamura","year":"2016","journal-title":"Nat Commun"},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1797.2010.01439.x","article-title":"Alteration in the phenotype of macrophages in the repair of renal interstitial fibrosis in mice","volume":"16","author":"Kushiyama","year":"2011","journal-title":"Nephrology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.06.028","article-title":"New insights into disease-specific absence of complement factor h related protein c in mouse models of spontaneous autoimmune diseases","volume":"62","author":"G. Mehta","year":"2014","journal-title":"Mol Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1030198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T12:54:27Z","timestamp":1680094467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1030198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2023.1030198"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1030198","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2023.1030198.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2023.1030198.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2023.1030198.s003","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"article-number":"1030198"}}